Compare · EXAS vs HUM
EXAS vs HUM
Side-by-side comparison of Exact Sciences Corporation (EXAS) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EXAS and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $51.90B, about 4.3x EXAS ($12.19B).
- HUM has hit the wire 13 times in the past 4 weeks while EXAS has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- Exact Sciences Corporation
- Humana Inc.
- Price
- -
- -
- Market cap
- $12.19B
- $51.90B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2001
- News (4w)
- 0
- 13
- Recent ratings
- 25
- 25
Exact Sciences Corporation
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest EXAS
- SEC Form 15-12G filed by Exact Sciences Corporation
- Amendment: SEC Form SCHEDULE 13G/A filed by Exact Sciences Corporation
- SEC Form POSASR filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
- SEC Form S-8 POS filed by Exact Sciences Corporation
Latest HUM
- Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
- SEC Form 8-K filed by Humana Inc.
- Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
- Humana upgraded by Raymond James with a new price target
- After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports
- Humana upgraded by Robert W. Baird with a new price target
- Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027
- SEC Form 8-K filed by Humana Inc.
- Humana upgraded by Cantor Fitzgerald with a new price target
- Humana Generates Nearly $20 Billion in Economic Impact Across Kentucky, New Report Finds